Rapidly progressing secondary organizing pneumonia due to underlying immunosuppression with rituximab in sars-cov-2 patients

HIGHLIGHTS

  • What: A growing body of evidence suggests that secondary organizing pneumonia needs to be strongly considered in the differential of patients with SARS-CoV-2 pneumonia presenting with persistent or relapsing respiratory symptoms and progression of radiological features.
  • Who: Report and colleagues from the Internal Medicine, University of North Carolina (UNC) Health Blue Ridge, Morganton, USA Pathology, University have published the research: Review began 04/27/2024 Review ended 05/11/2024 Published 05/15/2024 © Copyright, in the Journal: (JOURNAL) of May/15,/2024
  • Future: Corticosteroids remain the cornerstone of therapy although . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?